转移性肾癌联合药物治疗的肾毒性

Cancer Urology Pub Date : 2023-11-16 DOI:10.17650/1726-9776-2023-19-3-153-162

K. Titov, E. V. Shutov, A. A. Alimov, S. S. Lebedev, A. Kirichek, G. M. Zapirov

{"title":"转移性肾癌联合药物治疗的肾毒性","authors":"K. Titov, E. V. Shutov, A. A. Alimov, S. S. Lebedev, A. Kirichek, G. M. Zapirov","doi":"10.17650/1726-9776-2023-19-3-153-162","DOIUrl":null,"url":null,"abstract":"The review covers reduced kidney function in the context of renal cell carcinoma. According to international studies, some patients already have chronic kidney disease at time of disease onset. Surgical treatment leads to a decrease in the total number of functioning nephrons. Drug therapy causes several adverse events including nephrotoxicity. The review discusses the problem of using combination regimens in patients with solitary kidney.","PeriodicalId":216890,"journal":{"name":"Cancer Urology","volume":"27 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nephrotoxicity of combination drug therapy in metastatic renal cancer\",\"authors\":\"K. Titov, E. V. Shutov, A. A. Alimov, S. S. Lebedev, A. Kirichek, G. M. Zapirov\",\"doi\":\"10.17650/1726-9776-2023-19-3-153-162\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The review covers reduced kidney function in the context of renal cell carcinoma. According to international studies, some patients already have chronic kidney disease at time of disease onset. Surgical treatment leads to a decrease in the total number of functioning nephrons. Drug therapy causes several adverse events including nephrotoxicity. The review discusses the problem of using combination regimens in patients with solitary kidney.\",\"PeriodicalId\":216890,\"journal\":{\"name\":\"Cancer Urology\",\"volume\":\"27 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/1726-9776-2023-19-3-153-162\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/1726-9776-2023-19-3-153-162","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

该综述涉及肾细胞癌背景下的肾功能减退。根据国际研究，一些患者在发病时已经患有慢性肾病。手术治疗会导致功能正常的肾小球总数减少。药物治疗会导致多种不良反应，包括肾毒性。这篇综述讨论了单肾患者使用联合疗法的问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Nephrotoxicity of combination drug therapy in metastatic renal cancer

The review covers reduced kidney function in the context of renal cell carcinoma. According to international studies, some patients already have chronic kidney disease at time of disease onset. Surgical treatment leads to a decrease in the total number of functioning nephrons. Drug therapy causes several adverse events including nephrotoxicity. The review discusses the problem of using combination regimens in patients with solitary kidney.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer Urology

自引率

0.00%

发文量